Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction.

BACKGROUND The extent of microvascular obstruction during acute coronary occlusion may determine the eventual magnitude of myocardial damage and thus, patient prognosis after infarction. By contrast-enhanced MRI, regions of profound microvascular obstruction at the infarct core are hypoenhanced and correspond to greater myocardial damage acutely. We investigated whether profound microvascular obstruction after infarction predicts 2-year cardiovascular morbidity and mortality. METHODS AND RESULTS Forty-four patients underwent MRI 10 +/- 6 days after infarction. Microvascular obstruction was defined as hypoenhancement seen 1 to 2 minutes after contrast injection. Infarct size was assessed as percent left ventricular mass hyperenhanced 5 to 10 minutes after contrast. Patients were followed clinically for 16 +/- 5 months. Seventeen patients returned 6 months after infarction for repeat MRI. Patients with microvascular obstruction (n = 11) had more cardiovascular events than those without (45% versus 9%; P=.016). In fact, microvascular status predicted occurrence of cardiovascular complications (chi2 = 6.46, P<.01). The risk of adverse events increased with infarct extent (30%, 43%, and 71% for small [n = 10], midsized [n = 14], and large [n = 14] infarcts, P<.05). Even after infarct size was controlled for, the presence of microvascular obstruction remained a prognostic marker of postinfarction complications (chi2 = 5.17, P<.05). Among those returning for follow-up imaging, the presence of microvascular obstruction was associated with fibrous scar formation (chi2 = 10.0, P<.01) and left ventricular remodeling (P<.05). CONCLUSIONS After infarction, MRI-determined microvascular obstruction predicts more frequent cardiovascular complications. In addition, infarct size determined by MRI also relates directly to long-term prognosis in patients with acute myocardial infarction. Moreover, microvascular status remains a strong prognostic marker even after control for infarct size.

[1]  S B Reeder,et al.  Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. , 1997, Circulation.

[2]  G. Lamas,et al.  Ventricular dysfunction and the risk of stroke after myocardial infarction. , 1997, The New England journal of medicine.

[3]  R. Kim,et al.  Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.

[4]  R. Califf,et al.  Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial. , 1996, Circulation.

[5]  R. Pettigrew,et al.  Myocardial suppression in vivo by spin locking with composite pulses , 1996, Magnetic resonance in medicine.

[6]  Y. Taniyama,et al.  Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. , 1996, Circulation.

[7]  M. Hori,et al.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.

[8]  P. Menasché,et al.  Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass. , 1995, Circulation.

[9]  R. Judd,et al.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. , 1995, Circulation.

[10]  E. Atalar,et al.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. , 1995, Circulation.

[11]  B. Gersh,et al.  Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. , 1995, Circulation.

[12]  E. McVeigh,et al.  A magnetization‐driven gradient echo pulse sequence for the study of myocardial perfusion , 1995, Magnetic resonance in medicine.

[13]  W. Hundley,et al.  Measurement of absolute epicardial coronary artery flow and flow reserve with breath-hold cine phase-contrast magnetic resonance imaging. , 1995, Circulation.

[14]  M. Verani,et al.  Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. , 1995, Journal of the American College of Cardiology.

[15]  U. Sechtem,et al.  Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. , 1995, Circulation.

[16]  S. Kaul,et al.  Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. , 1994, Circulation.

[17]  G. Lamas,et al.  Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril , 1994, Circulation.

[18]  V. Wedeen,et al.  Time of flight quantification of coronary flow with echo‐planar MRI , 1993, Magnetic resonance in medicine.

[19]  L Axel,et al.  Regional differences in function within noninfarcted myocardium during left ventricular remodeling. , 1993, Circulation.

[20]  E. Negri,et al.  Determinants of 6‐Month Mortality in Survivors of Myocardial Infarction After Thrombolysis Results of the GISSI‐2 Data Base , 1993, Circulation.

[21]  P. V. van Dijkman,et al.  Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size. , 1993, The American journal of cardiology.

[22]  R. Edelman,et al.  A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. , 1993, The New England journal of medicine.

[23]  A. Weyman,et al.  Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. , 1993, Journal of the American College of Cardiology.

[24]  A. Kitabatake,et al.  Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.

[25]  R. Edelman,et al.  First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. , 1991, Journal of the American College of Cardiology.

[26]  B. Gersh,et al.  Relation of left ventricular volume and function over one year after acute myocardial infarction to infarct size determined by technetium-99m sestamibi. , 1991, The American journal of cardiology.

[27]  A. Maggioni,et al.  Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). , 1991, BMJ.

[28]  E J Topol,et al.  Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials. , 1990, Circulation.

[29]  L. Becker,et al.  Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. , 1990, Journal of the American College of Cardiology.

[30]  R. Gibbons,et al.  Prevention of late ventricular dilatation after acute myocardial infarction by successful thrombolytic reperfusion. , 1990, The American journal of cardiology.

[31]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[32]  L. Becker,et al.  Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. , 1989, Circulation.

[33]  P. Marino,et al.  Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. , 1989, Journal of the American College of Cardiology.

[34]  J. Felmlee,et al.  Adaptive technique for high-definition MR imaging of moving structures. , 1989, Radiology.

[35]  R. Califf,et al.  Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. , 1989, Circulation.

[36]  L. Bolognese,et al.  RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.

[37]  Dwight E. Peake,et al.  Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase , 1988 .

[38]  M. Verani,et al.  Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location. , 1988, The American journal of cardiology.

[39]  E. Topol,et al.  A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. , 1987, The New England journal of medicine.

[40]  D. Kass,et al.  Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. , 1987, Circulation.

[41]  H. White,et al.  Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. , 1987, The New England journal of medicine.

[42]  R Roberts,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.

[43]  W Grossman,et al.  Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. , 1986, Circulation.

[44]  J. Schofer,et al.  Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis. , 1985, Journal of the American College of Cardiology.

[45]  R. Califf,et al.  Myocardial infarction and stroke , 1984, Neurology.

[46]  E. Braunwald,et al.  Drug-induced expansion of infarct: morphologic and functional correlations. , 1984, Circulation.

[47]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.

[48]  N. Reichek,et al.  Anatomic Validation of Left Ventricular Mass Estimates from Clinical Two‐dimensional Echocardiography: Initial Results , 1983, Circulation.

[49]  E. Braunwald,et al.  The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.

[50]  F. Buonanno,et al.  Quantification of Experimental Myocardial Infarction Using Nuclear Magnetic Resonance Imaging and Paramagnetic Ion Contrast Enhancement in ExcisedCanine Hearts , 1982, Circulation.

[51]  J. Weiss,et al.  Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. , 1982, The American journal of cardiology.

[52]  R. Kloner,et al.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.

[53]  W. Roberts,et al.  Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm. , 1974, The American journal of medicine.

[54]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[55]  J. Hochman,et al.  Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. , 1987, Circulation.

[56]  Harold T. Dodge,et al.  Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* , 1987 .

[57]  G. Lamas,et al.  Increased left ventricular volume following myocardial infarction in man. , 1986, American heart journal.